Protein Purification and Isolation Market Size Worth USD 28.47 Billion by 2034 | CAGR: 10.67%

The protein purification and isolation market size is expected to reach USD 28.47 billion by 2034, according to a new study by Polaris Market Research. The report “Protein Purification and Isolation Market Share, Size, Trends, Industry Analysis Report By Product (Instruments, Consumables), By Technology, By Application, By End Use, By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Protein purification and isolation are critical preparatory processes used to obtain functionally active and highly purified proteins from complex biological mixtures. This market is driven by the rapid advancements in purification technologies, which are enhancing the precision, speed, and scalability of protein separation. There is a growing need for methods that can deliver high-yield and contamination-free outputs as research becomes increasingly focused on protein structure and function. Integration of automation, miniaturization, and high-throughput screening streamlines workflows, making these technologies more efficient and accessible for diverse end users in life sciences and drug discovery.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/protein-purification-and-isolation-market/request-for-sample

The protein purification and isolation market is further driven by the rising demand for protein-based therapeutics across multiple disease areas. The growing focus on biologics, such as monoclonal antibodies, vaccines, and enzymes, has increased the need for robust and reproducible purification techniques. This trend is further supported by ongoing efforts in therapeutic development, requiring consistent and scalable production of high-purity proteins. Therefore, as biologics continue to gain traction in the pharmaceutical pipeline, the importance of efficient protein purification tools boosts, reinforcing the market’s sustained growth.

Top of FormProtein Purification and Isolation Market Report Highlights

• In terms of product, the consumables segment dominated the market in 2024, due to recurring use and versatility across purification workflows. Their essential role in daily operations sustained market leadership.
• Based on technology, the electrophoresis segment is projected for robust expansion, due to precise protein analysis. Its accuracy in assessing molecular properties drives adoption in research and quality control.
• North America held 37.1% global share in 2024 due to advanced infrastructure, strong presence of biotech/pharma companies, and high adoption of technological advancements.
• The market in Asia Pacific is expected to witness the fastest growth with a 12.87% CAGR during 2025–2034 due to the research investments that boost biopharma production and favorable policies that accelerate the development.
• A few global key players in the protein purification and isolation market include Abcam Limited; Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; Danaher Corporation (Cytiva); Merck KGaA; Promega Corporation; QIAGEN; Revvity; Sartorius AG; and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the protein purification and isolation market report on the basis of product, technology, application, end use, and region:

By Product Outlook (Revenue, USD Billion, 2020–2034)

• Instruments
• Consumables

• Kits
• Reagents
• Columns
• Magnetic Beads
• Resins
• Others

By Technology Outlook (Revenue, USD Billion, 2020–2034)

• Ultrafiltration
• Precipitation
• Chromatography
  • Ion Exchange Chromatography
  • Affinity Chromatography
  • Reversed Phase Chromatography
  • Size Exclusion Chromatography
  • Hydrophobic Interaction Chromatography
• Electrophoresis
  • Gel Electrophoresis
  • Isoelectric Focusing
  • Capillary Electrophoresis
• Western Blotting
• Others

By Application Outlook (Revenue, USD Billion, 2020–2034)

• Drug Screening
• Biomarker Discovery
• Protein-Protein Interaction Studies
• Diagnostics

By End Use Outlook (Revenue, USD Billion, 2020–2034)

• Academic and Research Institutes
• Hospitals
• Pharmaceutical and Biotechnology Companies
• CROs

By Regional Outlook (Revenue, USD Billion, 2020–2034)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Vietnam
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa